Both in Pharmaceuticals
Ocular Therapeutix vs ANI Pharmaceuticals
Over the past year OCUL returned −36.8% and ANIP returned −23.1%; their daily moves had a correlation of 0.09.
OCUL −36.8% ANIP −23.1%Growth of $1, one year, split-adjusted
| Metric | OCUL | ANIP |
|---|---|---|
| Price | $7.29 | $71.71 |
| Market cap | $1.60B | $1.65B |
| Today | +8.48% | +0.76% |
| 1 month | −7.4% | −1.3% |
| 6 months | −20.8% | −8.0% |
| Year to date | −40.0% | −9.2% |
| 1 year | −36.9% | −22.8% |
| Revenue growth (YoY) | +0.1% | +25.9% |
| Gross margin | 85.1% | 62.4% |
| Net margin | −584.5% | 8.6% |
| P/E (TTM) | — | 16.5× |
| Price / sales | 30.8× | 1.7× |
| Net cash | $525.8M | -$234.7M |
| Dividend yield | — | — |
| Volatility (60d) | 75.9% | 29.5% |
| Short % of float | 15.1% | 18.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).